Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
Platelet gene expression and function in patients with COVID-19
2020 Standout
The organization of the human cerebral cortex estimated by intrinsic functional connectivity
2011 Standout
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172)
1993
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172
1989
Differences in specificity of heparin‐dependent antibodies developed in heparin‐induced thrombocytopenia and consequences on cross‐reactivity with danaparoid sodium
1997
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
2020 Standout
Parenteral Anticoagulants
2012 Standout
Heparin-Protein Interactions
2002 Standout
A review and synthesis of the first 20years of PET and fMRI studies of heard speech, spoken language and reading
2012 Standout
Therapeutic Interventions for Aphasia Initiated More than Six Months Post Stroke: A Review of the Evidence
2012
Potential therapeutic applications of the gut microbiome in obesity: from brain function to body detoxification
2020
Heparin-induced thrombocytopenia
1996
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Complications From Heparin-induced Thrombocytopenia in Patients Undergoing Cardiopulmonary Bypass
1993
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
2020
The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture
2016 Standout
Diagnostic and therapeutic strategies of white clot syndrome
1991
Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution
1997
Heparin-Induced Thrombocytopenia
1998
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
COVID-19 Pandemic: Cardiovascular Complications and Future Implications
2020
Coordinate‐based activation likelihood estimation meta‐analysis of neuroimaging data: A random‐effects approach based on empirical estimates of spatial uncertainty
2009 Standout
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
2020 Standout
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings
2006 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
Renewal of the Neurophysiology of Language: Functional Neuroimaging
2004
Plasmapheresis in the management of heparin‐associated thrombocytopenia with thrombosis
1988
HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE EFFECTS OF HEPARIN THERAPY
1998
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Heparin-induced thrombocytopenia and cardiac surgery
2003 Standout
A multi-modal parcellation of human cerebral cortex
2016 StandoutNature
Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies
1993
The human inferior parietal lobule in stereotaxic space
2008
A 14-year study of heparin-induced thrombocytopenia
1996 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Heparin
1991
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Photoplethysmography and its application in clinical physiological measurement
2007 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Outcomes from intensive care in patients with COVID‐19: a systematic review and meta‐analysis of observational studies
2020
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
On the Prophylactic and Therapeutic Use of Danaparoid Sodium (Orgaran®) in Patients With Heparin-Induced Thrombocytopenia
2003
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria
1995
The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness
2021
Heparin-Associated Thrombocytopenia: The Antibody Is Not Heparin Specific
1992
A Rapid and Sensitive Test for Diagnosing Heparin-Associated Thrombocytopenia
1991
The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia
1993
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]
1991
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Cytokine Storm
2020 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
COAGULATION DISORDERS IN CANCER
1996
Low-Molecular-Weight Heparins
1997 Standout
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
1995
Epidemiology of Aphasia Attributable to First Ischemic Stroke
2006
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
1992
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
The organization of the human cerebellum estimated by intrinsic functional connectivity
2011 Standout
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Immune Endothelial-Cell Injury in Heparin-Associated Thrombocytopenia
1987
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Assessment of the healing potentials of ulcers of the skin by photoplethysmography.
1979
Works of Maxime Leclerc being referenced
Cooking and co-ingested polyphenols reduce in vitro methylmercury bioaccessibility from fish and may alter exposure in humans
2017
High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients
2020
The white clot syndrome or heparin associated thrombocytopenia and thrombosis (WCS or HATT) (26 cases).
1986
Treatment of Heparin-Associated Thrombocytopenia and Thrombosis with Low Molecular Weight Heparin (CY 216)
1985
Vascular Aphasias
2002